The -629C > A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men

被引:53
作者
Eiriksdottir, G
Bolla, MK
Thorsson, B
Sigurdsson, G
Humphries, SE
Gudnason, V
机构
[1] Iceland Heart Assoc, Mol Genet Lab, IS-108 Reykjavik, Iceland
[2] UCL, Sch Med, Rayne Inst, Dept Med,Ctr Genet Cardiovasc Disorders, London W1N 8AA, England
关键词
CETP polymorphisms; HDL-C; myocardial infarct; risk of MI;
D O I
10.1016/S0021-9150(01)00489-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to examine whether the well-established effect of the common TaqIB polymorphism in intron I of the gene for cholesterol ester transfer protein (CETP) on high density lipoprotein cholesterol (HDL-C) concentration and increased risk of myocardial infarction (MI), could be explained by the recently identified - 629C > A functional polymorphism in the promoter. Non-fatal MI cases (388 male) and a control group of 794 healthy men were recruited from the 30 year long prospective Reykjavik Study. In the healthy men the frequency of the TaqIB B2 allele was 0.47 (95% CI: 0.44-0.50) and there was a strong allelic association with the - 629A allele (D = - 0.21, P < 0.0001), which had a frequency of 0.52 (95% CI: 0.49-0.56). B2B2 homozygotes displayed 15% higher HDL-C levels than subjects homozygous for the BI allele (P < 0.0001). Homozygotes for the - 629A allele displayed 14% higher HDL-C concentrations than subjects homozygous for the - 629C allele (P < 0.0001). The frequencies of the alleles associated with lower HDL-C were significantly higher in cases compared with controls, 0.59 versus 0.53 (TaqIB B1) and 0.52 versus 0.48 (-629 C) respectively (P < 0.05 for both). There was a significantly higher risk for MI in B I B I homozygotes (OR = 1.44, 95% CI: 1.10 - 1. 87, P < 0.01), compared to the other genotypes combined. This was not observed for the CC homozygotes (OR = 1.16, 95% CI: 0.87-1.54). In addition, homozygotes for the TaqI B2 allele experienced a first MI 2 years later than men with other genotypes, 59 versus 61 years (P < 0.05). This effect was not seen for the promoter polymorphism. These results strongly confirm the role of the CETP gene and the TaqIB variant as a risk factor for MI and suggest that another functional polymorphism is yet to be discovered in the CETP gene, that will explain the effect on MI associated with TaqIB observed in this study. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 28 条
[1]  
Bernard S, 1998, J LIPID RES, V39, P59
[2]   New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels - Role of Sp1/Sp3 in transcriptional regulation [J].
Dachet, C ;
Poirier, O ;
Cambien, F ;
Chapman, J ;
Rouis, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) :507-515
[3]   ELECTROPHORESIS FOR GENOTYPING - MICROTITER ARRAY DIAGONAL GEL-ELECTROPHORESIS ON HORIZONTAL POLYACRYLAMIDE GELS, HYDROLINK, OR AGAROSE [J].
DAY, INM ;
HUMPHRIES, SE .
ANALYTICAL BIOCHEMISTRY, 1994, 222 (02) :389-395
[4]   High-density lipoprotein cholesterol is related to the TaqIB cholesteryl ester transfer protein gene polymorphism and smoking, but not to moderate alcohol consumption in insulin-dependent diabetic men [J].
Dullaart, RPF ;
Beusekamp, BJ ;
Riemens, SC ;
Hoogenberg, K ;
Stulp, BK ;
Van Tol, A ;
Sluiter, WJ .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1998, 58 (03) :251-258
[5]   REGULATION OF PLASMA HDL CHOLESTEROL AND SUBFRACTION DISTRIBUTION BY GENETIC AND ENVIRONMENTAL-FACTORS - ASSOCIATIONS BETWEEN THE TAQI-B RFLP IN THE CETP GENE AND SMOKING AND OBESITY [J].
FREEMAN, DJ ;
GRIFFIN, BA ;
HOLMES, AP ;
LINDSAY, GM ;
GAFFNEY, D ;
PACKARD, CJ ;
SHEPHERD, J .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (03) :336-344
[6]  
FREEMAN DJ, 2000, ATHEROSCLEROSIS, V151, P91
[7]   ALCOHOL INTAKE MODULATES THE EFFECT OF A POLYMORPHISM OF THE CHOLESTERYL ESTER TRANSFER PROTEIN GENE ON PLASMA HIGH-DENSITY-LIPOPROTEIN AND THE RISK OF MYOCARDIAL-INFARCTION [J].
FUMERON, F ;
BETOULLE, D ;
LUC, G ;
BEHAGUE, I ;
RICARD, B ;
POIRIER, O ;
JEMAA, R ;
EVANS, A ;
ARVEILER, D ;
MARQUESVIDAL, P ;
BARD, JM ;
FRUCHART, JC ;
DUCIMETIERE, P ;
APFELBAUM, M ;
CAMBIEN, F .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) :1664-1671
[8]   HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714
[9]   Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations [J].
Gudnason, V ;
Kakko, S ;
Nicaud, V ;
Savolainen, MJ ;
Kesäniemi, YA ;
Tahvanainen, E ;
Humphries, S .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1999, 29 (02) :116-128
[10]  
Gudnason V, 1997, CLIN GENET, V51, P15